{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:32:59Z","timestamp":1771662779667,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.lfs.2021.119909","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017001","name":"Islamia University of Bahawalpur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lfs.2021.119909","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T22:52:43Z","timestamp":1629845563000},"page":"119909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["RETRACTED: Lipid poly (\u025b-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy"],"prefix":"10.1016","volume":"284","author":[{"given":"Safiullah","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Naeem","family":"Aamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asadullah","family":"Madni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrullah","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Jabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Abdur","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/21691401.2020.1867152","article-title":"Green synthesis of silver nanoparticles from Eriobotrya japonica extract: a promising approach against cancer cells proliferation, inflammation, allergic disorders and phagocytosis induction","volume":"49","author":"Jabir","year":"2021","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119909_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3322\/caac.21609","article-title":"Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"70","author":"Bray","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.lfs.2021.119909_bb0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/nano11020384","article-title":"Green synthesis of silver nanoparticles using annona muricata extract as an inducer of apoptosis in cancer cells and inhibitor for NLRP3 inflammasome via enhanced autophagy","volume":"11","author":"Jabir","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.lfs.2021.119909_bb0020","series-title":"Burden of Cancer in the Arab World","author":"Siddiqui","year":"2020"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119909_bb0025","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijpharm.2016.09.076","article-title":"Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells","volume":"513","author":"Safwat","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0030","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijbiomac.2019.12.007","article-title":"Carboxymethylcellulose-coated 5-fluorouracil@ MOF-5 nano-hybrid as a bio-nanocomposite carrier for the anticancer oral delivery","volume":"155","author":"Javanbakht","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2021.119909_bb0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.colsurfb.2018.09.027","article-title":"Dual responsive gelatin-based nanoparticles for enhanced 5-fluorouracil efficiency","volume":"172","author":"Mor\u00e1n","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.apsb.2014.12.001","article-title":"In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting","volume":"5","author":"Nasr","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2021.119909_bb0045","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijbiomac.2018.02.143","article-title":"Sesbania gum based hydrogel as platform for sustained drug delivery: an \u2018in vitro\u2019 study of 5-Fu release","volume":"113","author":"Pal","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2021.119909_bb0050","first-page":"1","article-title":"Lipid-polymer hybrid nanoparticles as a targeted drug delivery system for melanoma treatment","author":"Scopel","year":"2020","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"issue":"4","key":"10.1016\/j.lfs.2021.119909_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bioactmat.2017.07.002","article-title":"Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system","volume":"2","author":"Dave","year":"2017","journal-title":"Bioactive materials"},{"issue":"7","key":"10.1016\/j.lfs.2021.119909_bb0060","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3109\/03639045.2012.699069","article-title":"Design and evaluation of D-a tocopheryl polyethylene glycol 1000 succinate emulsified poly-?-caprolactone nanoparticles for protein\/peptide drug delivery","volume":"39","author":"Rayaprolu","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.msec.2017.03.011","article-title":"PCL foamed scaffolds loaded with 5-fluorouracil anti-cancer drug prepared by an eco-friendly route","volume":"75","author":"Salerno","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.lfs.2021.119909_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jddst.2017.02.012","article-title":"Design of lipid-polymer hybrid nanoparticles for therapy of BPH: part I. Formulation optimization using a design of experiment approach","volume":"39","author":"Sengel-Turk","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.lfs.2021.119909_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jddst.2019.03.039","article-title":"Docetaxel-loaded lipid-polymer hybrid nanoparticles for breast cancer therapeutics","volume":"51","author":"Jadon","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.lfs.2021.119909_bb0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.msec.2018.11.035","article-title":"Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles","volume":"96","author":"Abriata","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.lfs.2021.119909_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110576","article-title":"Lipid-PLGA hybrid nanoparticles of paclitaxel: preparation, characterization, in vitro and in vivo evaluation","volume":"109","author":"Godara","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.lfs.2021.119909_bb0090","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.2147\/IJN.S223368","article-title":"Physical pegylation enhances the cytotoxicity of 5-fluorouracil-loaded PLGA and PCL nanoparticles","volume":"14","author":"Ashour","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2021.119909_bb0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1208\/s12249-013-9943-3","article-title":"Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery","volume":"14","author":"Wang","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.lfs.2021.119909_bb0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/10837450.2015.1116565","article-title":"Preparation and in vitro evaluation of 5-fluorouracil-loaded PCL nanoparticles for colon cancer treatment","volume":"22","author":"\u00d6zt\u00fcrk","year":"2017","journal-title":"Pharm. Dev. Technol."},{"issue":"3","key":"10.1016\/j.lfs.2021.119909_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1328-9","article-title":"pH\/thermo-dual responsive tunable in situ cross-linkable depot injectable hydrogels based on poly (N-isopropylacrylamide)\/carboxymethyl chitosan with potential of controlled localized and systemic drug delivery","volume":"20","author":"Khan","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.lfs.2021.119909_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijbiomac.2020.01.019","article-title":"Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections","volume":"147","author":"Hassan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2021.119909_bb0115","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ijbiomac.2018.10.095","article-title":"Development of a photoresponsive chitosan conjugated prodrug nano-carrier for controlled delivery of antitumor drug 5-fluorouracil","volume":"121","author":"Horo","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119909_bb0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2010.11.025","article-title":"Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting","volume":"404","author":"Lai","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.biopha.2018.09.128","article-title":"A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes","volume":"108","author":"Handali","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2021.119909_bb0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clay.2014.09.004","article-title":"A study on sustained release formulations for oral delivery of 5-fluorouracil based on alginate\u2013chitosan\/montmorillonite nanocomposite systems","volume":"101","author":"Azhar","year":"2014","journal-title":"Appl. Clay Sci."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119909_bb0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2016.11.012","article-title":"Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil","volume":"516","author":"El-Hammadi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0140","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijbiomac.2016.11.098","article-title":"Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer","volume":"95","author":"Badran","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2021.119909_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119275","article-title":"Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery","volume":"581","author":"Tahir","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.lfs.2021.119909_bb0150","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1007\/s10904-020-01651-1","article-title":"Polyvinylpyrrolidone loaded-MnZnFe 2 O 4 magnetic nanocomposites induce apoptosis in cancer cells through mitochondrial damage and P 53 pathway","volume":"30","author":"Kareem","year":"2020","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"10.1016\/j.lfs.2021.119909_bb0155","article-title":"Enhanced in vitro release and permeability of glibenclamide by proliposomes: development, characterization and histopathological evaluation","volume":"63","author":"Khan","year":"2021","journal-title":"J. Deliv. Sci. Technol."},{"key":"10.1016\/j.lfs.2021.119909_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120363","article-title":"Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: In vivo toxicity evaluation","volume":"598","author":"Sadaquat","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01694-0","article-title":"Poloxamer-407-Co-Poly (2-acrylamido-2-methylpropane sulfonic acid) cross-linked nanogels for solubility enhancement of olanzapine: synthesis, characterization, and toxicity evaluation","volume":"21","author":"Khan","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0170","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1080\/10717544.2020.1837294","article-title":"Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid\u2013polymer hybrid nanoparticles","volume":"27","author":"Fu","year":"2020","journal-title":"Drug Deliv."},{"issue":"77","key":"10.1016\/j.lfs.2021.119909_bb0175","doi-asserted-by":"crossref","first-page":"62989","DOI":"10.1039\/C5RA12459J","article-title":"Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate","volume":"5","author":"Garg","year":"2015","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.lfs.2021.119909_bb0180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2019.09.004","article-title":"Improved oral delivery of tilianin through lipid\u2013polymer hybrid nanoparticles to enhance bioavailability","volume":"519","author":"Zeng","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2021.119909_bb0185","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.msec.2016.01.059","article-title":"Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: characterization and cellular cytotoxicity","volume":"62","author":"Esfandyari-Manesh","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.lfs.2021.119909_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118971","article-title":"In vitro anti-leukemic assessment and sustained release behaviour of cytarabine loaded biodegradable polymer based nanoparticles","volume":"267","author":"Jan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2021.119909_bb0195","doi-asserted-by":"crossref","unstructured":"U. Seju A. Kumar K. Sawant Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery. 2011, vitro.","DOI":"10.1016\/j.actbio.2011.07.025"},{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2017.09.061","article-title":"Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications","volume":"533","author":"Tahir","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0205","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2018.06.063","article-title":"Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design","volume":"548","author":"Yalcin","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.lfs.2021.119909_bb0210","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3109\/10717544.2014.948643","article-title":"Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery","volume":"23","author":"Alex","year":"2016","journal-title":"Drug Deliv."},{"issue":"11","key":"10.1016\/j.lfs.2021.119909_bb0215","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/03639045.2016.1180392","article-title":"Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation","volume":"42","author":"Devrim","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0220","first-page":"2101","article-title":"Folate-modified lipid\u2013polymer hybrid nanoparticles for targeted paclitaxel delivery","volume":"10","author":"Zhang","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2021.119909_bb0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.colsurfb.2011.02.033","article-title":"Factors affecting drug encapsulation and stability of lipid\u2013polymer hybrid nanoparticles","volume":"85","author":"Cheow","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0230","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejpb.2014.04.017","article-title":"In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N, O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies","volume":"88","author":"Anitha","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.lfs.2021.119909_bb0235","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/pat.4417","article-title":"Polycaprolactone\/chitosan blend nanofibers loaded by 5-fluorouracil: an approach to anticancer drug delivery system","volume":"29","author":"Hadjianfar","year":"2018","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.lfs.2021.119909_bb0240","article-title":"Impact of binary\/ternary solid dispersion utilizing poloxamer 188 and TPGS to improve pharmaceutical attributes of bedaquiline fumarate","volume":"62","author":"Pardhi","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0245","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.4067\/S0717-97072013000100012","article-title":"Preparation and characterization of solid dispersions of carvedilol with poloxamer 188","volume":"58","author":"Sharma","year":"2013","journal-title":"J. Chil. Chem. Soc."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119909_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2011.07.020","article-title":"Effects of amphiphilic PCL\u2013PEG\u2013PCL copolymer addition on 5-fluorouracil release from biodegradable PCL films for stent application","volume":"419","author":"Lu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejps.2019.02.006","article-title":"Enhanced transdermal permeation and anti-inflammatory potential of phospholipids complex-loaded matrix film of umbelliferone: formulation development, physico-chemical and functional characterization","volume":"131","author":"Telange","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119909_bb0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2017.07.060","article-title":"Improved metabolic stability and therapeutic efficacy of a novel molecular gemcitabine phospholipid complex","volume":"530","author":"Dora","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2015.10.021","article-title":"Development and in vitro evaluation of core\u2013shell type lipid\u2013polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer","volume":"81","author":"Mandal","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119909_bb0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2007.05.031","article-title":"Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188","volume":"343","author":"Newa","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.lfs.2021.119909_bb0275","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1590\/S0100-40422011000600004","article-title":"Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies","volume":"34","author":"Mello","year":"2011","journal-title":"Qu\u00edm. Nova"},{"issue":"1","key":"10.1016\/j.lfs.2021.119909_bb0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcis.2010.10.054","article-title":"Folate-functionalized nanoparticles for controlled 5-fluorouracil delivery","volume":"354","author":"Zhang","year":"2011","journal-title":"J. Colloid Interface Sci."},{"issue":"5","key":"10.1016\/j.lfs.2021.119909_bb0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/10717540802174662","article-title":"Etoposide-loaded PLGA and PCL nanoparticles I: preparation and effect of formulation variables","volume":"15","author":"Snehalatha","year":"2008","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.lfs.2021.119909_bb0290","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.lfs.2021.119909_bb0295","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.colsurfb.2017.08.042","article-title":"Polymer\u2013lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma","volume":"159","author":"Duan","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"}],"updated-by":[{"DOI":"10.1016\/j.lfs.2024.122887","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"record-id":"54700"},{"DOI":"10.1016\/j.lfs.2021.119909","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}},{"DOI":"10.1016\/j.lfs.2024.122887","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521008961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521008961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:18:14Z","timestamp":1752567494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521008961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":59,"alternative-id":["S0024320521008961"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119909","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.lfs.2024.122887","asserted-by":"object"}],"retraction":[{"id-type":"doi","id":"10.1016\/j.lfs.2021.119909","asserted-by":"object"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Lipid poly (\u025b-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119909"}}